Recent Blogs

SPECIAL BULLETIN COVID-19 #232: Hospice Room and Board Claims Reprocessing Due to Extension

Monday, February 28, 2022

SPECIAL BULLETIN COVID #231: Bebtelovimab Injection for Intravenous use HCPCS Code Q0222: Billing Guidelines

Monday, February 28, 2022

Community Alternatives Program for Children Waiver Renewal Update

Monday, February 28, 2022

SPECIAL BULLETIN COVID-19 #230: Update on Temporary Rate Increases and HCBS Rate Implementation

Wednesday, February 23, 2022

NC Medicaid Managed Care Provider Update – Feb. 23, 2022

Wednesday, February 23, 2022

Medicaid for Pregnant Beneficiaries Extended to 12 Months After Birth

Tuesday, February 22, 2022

Updates to Clinical Coverage Policy 5B Orthotics and Prosthetics

Tuesday, February 15, 2022

Attention Enrolling Providers: NEW NC Medicaid Provider Training is LIVE!

Thursday, February 10, 2022

Inclisiran Injection, for Subcutaneous Use (Leqvio®) HCPCS Code J3490: Billing Guidelines

Tuesday, February 08, 2022

Ropeginterferon alfa-2b-njft Injection, for Subcutaneous Use (BESREMI®) HCPCS Code J3590: Billing Guidelines

Tuesday, February 08, 2022

Efgartigimod Alfa-fcab Injection, for Intravenous Use (VYVGART™) HCPCS Code J3590: Billing Guidelines

Tuesday, February 08, 2022

SPECIAL BULLETIN COVID-19 #229: Direct Care Worker Eligibility and Portal Guidance Clarifications

Friday, February 04, 2022